Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmalink Extracts Europe is the European division of Pharmalink International, a biotechnology company specializing in the development and manufacture of marine-based nutraceuticals. The company is best known for its proprietary green-lipped mussel oil extract, PCSO-524, which is marketed globally under the brand name Lyprinol. Utilizing advanced supercritical CO2 extraction technology, Pharmalink produces high-purity lipid fractions designed to manage inflammatory conditions such as osteoarthritis and asthma. Their business model focuses on the research, production, and distribution of scientifically validated natural health products. The company maintains a strong emphasis on clinical validation, collaborating with academic institutions to demonstrate the efficacy of its marine extracts in human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmalink Extracts Europe.